The current recorded case count for COVID-19 (coronavirus) in the UK has hit 3,269, with 144 deaths and 65 recoveries.
News
£27 million pledged to fight “world’s biggest killers”
The company will be able to accelerate the development of an innovative drug and technology pipeline, born from The George Institute’s research program.
FDA OKs Gilead’s paediatric hep C drug
Epclusa is the first pan-genotypic, protease inhibitor-free regimen approved in the United States for adults and children.
Ex-NHS workers told “Your NHS Needs You”
The recruitment drive is aimed at more than 65,000 former nurses and doctors.
COVID-19: Roche starts clinical trial as UK cases continue to rise
The current recorded case count for COVID-19 (coronavirus) in the UK has hit 2,626, with 104 deaths and 65 recoveries.
NHS data shows gap in care for heart failure patients
Potentially a third of people with heart failure are not being screened for iron deficiency and iron deficiency anaemia, with potentially debilitating effects on their quality of life.
Pfizer’s abrocitinib hits endpoints in late-stage atopic dermatitis study
The data will support filings with regulatory bodies, starting with the FDA later this year.
AbbVie, Allergan megamerger set for May close
Despite the two businesses putting planning in place, Bloomberg recently reported that mergers in the US may face further delays due to the COVID-19 outbreak.
Oxford Biomedica to license LentiVector to Juno
The deal makes the platform available for application in Juno’s CAR-T and TCR-T programmes in oncology and other indications.
Imfinzi, tremelimumab combo flunks SCLC trial
Data from the Phase III CASPIAN trial has shown that the addition of tremelimumab to Imfinzi did not significantly improve overall survival.
Higher dose of gefapixant hits endpoints in chronic cough trial
On the other hand, the gefapixant 15mg twice daily treatment arms did not meet the primary efficacy endpoint.
COVID-19: Pfizer, Regeneron to develop candidates, but solution likely to ‘be a year away’
As the case count for COVID-19 (coronavirus) in the UK hits 1950, pharma companies continue to pitch in with their efforts.
COVID-19: Sanofi, Moderna, BioNTech give updates
The announcements follow government issued advice to avoid all non-essential travel and contact in the UK.
Novo cancels haemophilia drug Phase III trial
Haemophilia is a mostly inherited genetic disorder that impairs the body’s ability to make blood clots.
New research discovers cells linked to Alzheimer’s and autism
The new insight into the architecture of the brain is the most in-depth study of its kind.
